Figure 4 Towards more physiologically relevant 2D

Slides:



Advertisements
Similar presentations
Cell Delivery Mechanisms for Tissue Repair
Advertisements

Figure 2 Genetic organization and translation of hepatitis E virus
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Enteroids can model transport physiology
promotes the oncogenic activity of CagA
Figure 3 Neutrophils in liver inflammation
Figure 3 Extracellular stimuli to HSC activation
Figure 5 Dendritic cells in liver inflammation
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 6 Injection of mesenchymal stem cells in perianal fistulas
Figure 1 Gut microorganisms at the intersection of several diseases
Figure 5 Two approaches to therapeutic genome editing
Figure 3 Life cycle of hepatitis E virus
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Immune mechanisms in liver homeostasis
Figure 1 Biosimilar development process
Sayaka Sekiya, Shizuka Miura, Kanae Matsuda-Ito, Atsushi Suzuki 
Figure 2 Effect of PPIs on gastric physiology
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Suggested biopsy-avoiding diagnostic pathway for coeliac disease Figure 1 | Suggested biopsy-avoiding diagnostic pathway for coeliac disease.
Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.
Figure 1 Definition and concept of ACLF
Figure 1 Functions, features and phenotypes of HSCs in normal and diseased livers Figure 1 | Functions, features and phenotypes of HSCs in normal and diseased.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Host range of hepatitis E virus
Figure 2 Switching of biologic agents and biosimilars
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Overview of the immunopathogenesis of ulcerative colitis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 The mechanism of injury in ACLF
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
to the liver and promote patient-derived xenograft tumour growth
Figure 7 Example colonic high-resolution manometry
Figure 1 Environmental factors contributing to IBD pathogenesis
different types of liver cells
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 5 Hepatic regeneration in ACLF
Figure 2 13C-octanoic acid gastric emptying breath test
in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)
Figure 5 Chrononutrition in the liver
Atsushi Miyajima, Minoru Tanaka, Tohru Itoh  Cell Stem Cell 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 6 Possible therapeutic targets to decrease hepatic steatosis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Schematic of normal and abnormal liver regeneration
Cell Delivery Mechanisms for Tissue Repair
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 Strategies to improve liver regeneration
Figure 1 Brain–gut axis Brain–gut axis. Schematic of the brain–gut axis, including inputs from the gut microbiota, the ENS, the immune system and the external.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 6 Innate lymphoid cells in liver inflammation
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Construction and analysis of the HEV-host PPI network.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 5 Systems biological model of IBS
Figure 1 Mucosal immune networks
Figure 4 Local species pools that contribute to the
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Distribution of markers of active HBV infection
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Lifelong influences on the gut microbiome from
Figure 1 NAFLD pathogenesis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Presentation transcript:

Figure 4 Towards more physiologically relevant 2D and 3D cell culture models for studying hepatitis E virus Figure 4 | Towards more physiologically relevant 2D and 3D cell culture models for studying hepatitis E virus. The species permissive to hepatitis E virus (HEV) infection include (but are not limited to) humans, rabbits, swine, deer, wild boar and camel. To better study HEV infection in physiologically relevant in vitro models, it will be desirable to generate co-cultures that recapitulate the complexity of the liver including endothelial, stellate, cholangiocytic, Kupffer and hepatic cells in the appropriate ratios. These cells can be harvested from primary tissue or differentiated from stem cells and could be derived from the aforementioned species to explore viral host tropism. Primary cultures have the disadvantage of limited durability; this issue can be overcome by differentiating the various cell types from indefinitely self-renewing stem cells. This process, however, is technically challenging and requires advances in current hepatic differentiation protocols. Incorporating primary-cell-derived and stem-cell-derived tissues into a 3D architecture will also be important to more closely mimic the physiological hepatic environment and preserve cell morphology. The architecture of the liver leads to heterogeneous environmental cues (e.g. nutrients, oxygen, inflammatory factors, etc) reaching individual cells, and 3D cultures can better capture this phenomenon. Furthermore, it was previously shown that primary human hepatocyte dedifferentiation can be delayed or prevented in collagen sandwich cultures, by aggregation in spheroids, or in co-culture with non-parenchymal cells. Nimgaonkar, I. et al. (2017) Hepatitis E virus: advances and challenges Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.150